The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...

The VRBPAC meeting comes the week after the World Health Organization (WHO) recommended that members consider using ...

"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...

The Food and Drug Administration unveiled plans Tuesday to narrow its approval for updated coronavirus vaccines to older ...

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

Advisers to the U.S. Food and Drug Administration will discuss recommendations for updated COVID-19 vaccines ahead of the ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...

The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk, ...

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans — a move that will limit ...

In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...